Long‐term renal prognosis and risk for hypertension after myeloablative therapies in survivors of childhood high‐risk neuroblastoma: A nationwide study-Reference-Cited by-同舟云学术

Long‐term renal prognosis and risk for hypertension after myeloablative therapies in survivors of childhood high‐risk neuroblastoma: A nationwide study

Published:2020-05-30 Issue:8 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Suominen Anu¹^ORCID,Jahnukainen Timo²,Ojala Tiina H.³,Sarkola Taisto³,Turanlahti Maila³,Saarinen‐Pihkala Ulla M.¹,Jahnukainen Kirsi¹⁴

Affiliation:

1. Division of Hematology‐Oncology and Stem Cell TransplantationChildren's HospitalUniversity of Helsinki and Helsinki University Hospital, Helsinki Finland

2. Division of Pediatric Nephrology and TransplantationChildren's HospitalUniversity of Helsinki and Helsinki University Hospital, Helsinki Finland

3. Division of Cardiology, Children's HospitalUniversity of Helsinki and Helsinki University Hospital, Helsinki Finland

4. Department of Women's and Children's HealthKarolinska Institute and University Hospital Stockholm Sweden

Funder

Lastentautien Tutkimussäätiö

Sigrid Juséliuksen Säätiö

Lasten Syöpäsäätiö Väreen

Syöpäjärjestöt

Academy of Finland

Publisher

Wiley

Subject